Akèy › Kansè Vezik ki pa envazif miskilè › Texas › San Antonio
Etid klinik pou Kansè Vezik ki pa envazif miskilè nan San Antonio, TX
6 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan ak bò kote San Antonio (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ap rekriteFaz 2
- Urology San Antonio, San Antonio
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Ap rekriteFaz 3
- Urology San Antonio PA dba USA Clinical Trials, San Antonio
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Ap rekriteFaz 1
- Baptist M&S Imaging (Medical Center), San Antonio
- USA Clinical Trials, San Antonio
- MCOA Eye Associates, San Antonio
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
Ap rekriteEtid obsèvasyon
- University of Texas Health Science Center at San Antonio, San Antonio
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Ap rekriteFaz 2
- UT Health San Antonio, San Antonio
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Ap rekriteFaz 1/2
- University of Texas Health Science Center at San Antonio, San Antonio
Etid Kansè Vezik ki pa envazif miskilè nan lòt vil
- Columbus, OH10 etid
- Dallas, TX10 etid
- New York City, NY10 etid
- Myrtle Beach, SC9 etid
- Edison, NJ9 etid
- Baltimore, MD8 etid
- Syracuse, NY8 etid
- Nashville, TN8 etid
- Houston, TX7 etid
- Indianapolis, IN7 etid
- Philadelphia, PA7 etid
- Birmingham, AL7 etid
Lòt etid nan San Antonio
- Kansè Poumon ki pa ti selil59 etid
- Kansè nan tete47 etid
- Kansè kolorektal46 etid
- Kansè Metastatik44 etid
- Kansè (tout kalite)41 etid
- Obèsite40 etid
- Dyabèt Tip 237 etid
- Sipwa34 etid
- Kansè ovè31 etid
- Kansè pankreyas31 etid
- Kansè pwostat28 etid
- Kansè Endomèt27 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.